Follow the people · Insider
Todd Wider
Todd Wider files insider transactions with the SEC as a director of ASP Isotopes (ASPI). We hold 2 disclosed purchases and sales filed since 19 June 2015, 2 of them in the last 90 days.
- Files forASPI
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure1 July 2026
Positions held
4 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 15 November 2022 — 30 June 2026Director · ASP Isotopes (ASPI)13 Form 4 lines · source: SEC Form 4
- Filed 31 July 2024 — 31 July 2024Director · ARYA Sciences Acquisition Corp IV (ARYD)1 Form 4 line · source: SEC Form 4
- Filed 11 May 2015 — 26 September 2022Director · Abeona Therapeutics (ABEO)54 Form 4 lines · source: SEC Form 4
- Filed 1 July 2020 — 1 July 2020Director · Arya Sciences Acquisition (ARYA)1 Form 4 line · source: SEC Form 4
Everything they disclosed
69 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 50,000 shares of ASP IsotopesSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 50,000 shares of ASP IsotopesSEC Form 41 July 2026Common Stock · traded 30 June 2026 · filed 1 July 2026
- was granted 36,548 shares of ASP IsotopesSEC Form 422 December 2025Common Stock · traded 18 December 2025 · filed 22 December 2025
- was granted 25,469 shares of ASP IsotopesSEC Form 414 November 2025Common Stock · traded 12 November 2025 · filed 14 November 2025
- exercised options over 96,000 shares of ASP Isotopes (a derivative holding)SEC Form 43 October 2025Stock Option (right to buy) · traded 14 September 2025 · filed 3 October 2025
- exercised options over 96,000 shares of ASP IsotopesSEC Form 43 October 2025Common Stock · traded 14 September 2025 · filed 3 October 2025
- had shares withheld for tax on 21,892 shares of ASP IsotopesSEC Form 43 October 2025Common Stock · traded 14 September 2025 · filed 3 October 2025
- ▼ sold on the open market 74,108 shares of ASP IsotopesSEC Form 43 October 2025Common Stock · traded 15 September 2025 · filed 3 October 2025
- was granted 42,522 shares of ASP IsotopesSEC Form 421 November 2024Common Stock · traded 20 November 2024 · filed 21 November 2024
- was granted 77,626 shares of ASP IsotopesSEC Form 414 August 2024Common Stock · traded 13 August 2024 · filed 14 August 2024
- was granted 95,238 shares of ASP IsotopesSEC Form 414 August 2024Common Stock · traded 13 August 2024 · filed 14 August 2024
- returned to the issuer 30,000 shares of ARYA Sciences Acquisition Corp IV (a derivative holding)SEC Form 431 July 2024Class B ordinary shares · traded 31 July 2024 · filed 31 July 2024
- ▲ bought on the open market 94,844 shares of ASP IsotopesSEC Form 430 October 2023Common Stock · traded 26 October 2023 · filed 30 October 2023
- was granted 200,000 shares of ASP IsotopesSEC Form 416 November 2022Common Stock · traded 15 November 2022 · filed 16 November 2022
- was granted 13,400 shares of Abeona TherapeuticsSEC Form 428 September 2022Common Stock · traded 26 September 2022 · filed 28 September 2022
- ▼ sold on the open market 25,000 shares of Abeona TherapeuticsSEC Form 48 October 2021Common Stock · traded 7 October 2021 · filed 8 October 2021
- was granted 38,590 shares of Abeona TherapeuticsSEC Form 427 May 2021Common Stock · traded 25 May 2021 · filed 27 May 2021
- was granted 49,084 shares of Abeona Therapeutics (a derivative holding)SEC Form 427 May 2021Stock Option (right to buy) · traded 25 May 2021 · filed 27 May 2021
- ▼ sold on the open market 251,625 shares of Abeona TherapeuticsSEC Form 423 February 2021Common Stock · traded 19 February 2021 · filed 23 February 2021
- exercised options over 100,000 shares of Abeona TherapeuticsSEC Form 419 February 2021Common Stock · traded 17 February 2021 · filed 19 February 2021
- exercised options over 50,000 shares of Abeona TherapeuticsSEC Form 419 February 2021Common Stock · traded 17 February 2021 · filed 19 February 2021
- exercised options over 50,000 shares of Abeona TherapeuticsSEC Form 419 February 2021Common Stock · traded 17 February 2021 · filed 19 February 2021
- exercised options over 30,000 shares of Abeona TherapeuticsSEC Form 419 February 2021Common Stock · traded 17 February 2021 · filed 19 February 2021
- exercised options over 50,000 shares of Abeona TherapeuticsSEC Form 419 February 2021Common Stock · traded 17 February 2021 · filed 19 February 2021
- exercised options over 19,827 shares of Abeona TherapeuticsSEC Form 419 February 2021Common Stock · traded 17 February 2021 · filed 19 February 2021
- exercised options over 20,173 shares of Abeona TherapeuticsSEC Form 419 February 2021Common Stock · traded 17 February 2021 · filed 19 February 2021
- ▼ sold on the open market 320,000 shares of Abeona TherapeuticsSEC Form 419 February 2021Common Stock · traded 17 February 2021 · filed 19 February 2021
- exercised options over 1,345 shares of Abeona TherapeuticsSEC Form 419 February 2021Common Stock · traded 18 February 2021 · filed 19 February 2021
- ▼ sold on the open market 1,345 shares of Abeona TherapeuticsSEC Form 419 February 2021Common Stock · traded 18 February 2021 · filed 19 February 2021
- exercised options over 100,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 419 February 2021Stock Option (Right to Buy) · traded 17 February 2021 · filed 19 February 2021
- exercised options over 50,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 419 February 2021Stock Option (Right to Buy) · traded 17 February 2021 · filed 19 February 2021
- exercised options over 50,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 419 February 2021Stock Option (Right to Buy) · traded 17 February 2021 · filed 19 February 2021
- exercised options over 30,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 419 February 2021Stock Option (Right to Buy) · traded 17 February 2021 · filed 19 February 2021
- exercised options over 50,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 419 February 2021Stock Option (Right to Buy) · traded 17 February 2021 · filed 19 February 2021
- exercised options over 19,827 shares of Abeona Therapeutics (a derivative holding)SEC Form 419 February 2021Stock Option (Right to Buy) · traded 17 February 2021 · filed 19 February 2021
- exercised options over 20,173 shares of Abeona Therapeutics (a derivative holding)SEC Form 419 February 2021Stock Option (Right to Buy) · traded 17 February 2021 · filed 19 February 2021
- exercised options over 1,345 shares of Abeona Therapeutics (a derivative holding)SEC Form 419 February 2021Stock Option (Right to Buy) · traded 18 February 2021 · filed 19 February 2021
- returned to the issuer 609,755 shares of Abeona TherapeuticsSEC Form 45 January 2021Common Stock · traded 31 December 2020 · filed 5 January 2021
- ▼ sold on the open market 33,876 shares of Abeona TherapeuticsSEC Form 45 January 2021Common Stock · traded 4 January 2021 · filed 5 January 2021
- ▼ sold on the open market 33,876 shares of Abeona TherapeuticsSEC Form 42 December 2020Common Stock · traded 2 December 2020 · filed 2 December 2020
- ▼ sold on the open market 17,969 shares of Abeona TherapeuticsSEC Form 424 November 2020Common Stock · traded 23 November 2020 · filed 24 November 2020
- was granted 21,518 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- returned to the issuer 21,518 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- was granted 19,827 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- returned to the issuer 19,827 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- was granted 50,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- returned to the issuer 50,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- was granted 30,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- returned to the issuer 30,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- was granted 50,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- returned to the issuer 50,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- was granted 50,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- returned to the issuer 50,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- was granted 100,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- returned to the issuer 100,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 420 November 2020Stock Option (right to buy) · traded 20 November 2020 · filed 20 November 2020
- ▼ sold on the open market 33,876 shares of Abeona TherapeuticsSEC Form 46 November 2020Common Stock · traded 2 November 2020 · filed 6 November 2020
- was granted 813,008 shares of Abeona TherapeuticsSEC Form 413 October 2020Common Stock · traded 8 October 2020 · filed 13 October 2020
- returned to the issuer 30,000 shares of Arya Sciences Acquisition (a derivative holding)SEC Form 46 July 2020Class B Ordinary Shares · traded 1 July 2020 · filed 6 July 2020
- was granted 21,518 shares of Abeona Therapeutics (a derivative holding)SEC Form 422 May 2020Stock Option (right to buy) · traded 20 May 2020 · filed 22 May 2020
- was granted 17,969 shares of Abeona TherapeuticsSEC Form 422 May 2020Common Stock · traded 20 May 2020 · filed 22 May 2020
- was granted 19,827 shares of Abeona Therapeutics (a derivative holding)SEC Form 423 May 2019Stock Option (right to buy) · traded 21 May 2019 · filed 23 May 2019
- was granted 30,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 418 December 2017Stock option (right to buy) · traded 14 December 2017 · filed 18 December 2017
- was granted 50,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 415 December 2016Stock option (right to buy) · traded 13 December 2016 · filed 15 December 2016
- was granted 100,000 shares of Abeona TherapeuticsSEC Form 49 November 2016Common stock · traded 7 November 2016 · filed 9 November 2016
- ▲ bought on the open market 5,000 shares of Abeona TherapeuticsSEC Form 428 September 2016Common stock · traded 20 September 2016 · filed 28 September 2016
- was granted 50,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 416 February 2016Stock option (right to buy) · traded 11 February 2016 · filed 16 February 2016
- ▲ bought on the open market 20,000 shares of Abeona TherapeuticsSEC Form 43 August 2015Common stock · traded 31 July 2015 · filed 3 August 2015
- was granted 50,000 shares of Abeona TherapeuticsSEC Form 419 June 2015Common stock · traded 11 May 2015 · filed 19 June 2015
- was granted 100,000 shares of Abeona Therapeutics (a derivative holding)SEC Form 419 June 2015Stock option (right to buy) · traded 11 May 2015 · filed 19 June 2015
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.